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NRG1 variant effects in patients with
Hirschsprung disease
Gunadi1* , Nova Yuli Prasetyo Budi1, Raman Sethi2,3, Aditya Rifqi Fauzi1, Alvin Santoso Kalim1, Taufik Indrawan1,
Kristy Iskandar4, Akhmad Makhmudi1, Indra Adrianto5 and Lai Poh San2,3

Abstract
Background: Hirschsprung disease (HSCR) is a heterogeneous genetic disorder characterized by absence of ganglion
cells along the intestines resulting in functional bowel obstruction. Mutations in neuregulin 1 (NRG1) gene have been
implicated in some cases of intestinal aganglionosis. This study aims to investigate the contribution of the NRG1 gene
to HSCR development in an Indonesian population.
Methods: We analyzed the entire coding region of the NRG1 gene in 54 histopathologically diagnosed HSCR patients.
Results: All patients were sporadic non-syndromic HSCR with 53/54 (98%) short-segment and 1/54 (2%) long-segment
patients. NRG1 gene analysis identified one rare variant, c.397G > C (p.V133 L), and three common variants, rs7834206,
rs3735774, and rs75155858. The p.V133 L variant was predicted to reside within a region of high mammalian
conservation, overlapping with the promoter and enhancer histone marks of relevant tissues such as digestive
and smooth muscle tissues and potentially altering the AP-4_2, BDP1_disc3, Egr-1_known1, Egr-1_known4, HEN1_2
transcription factor binding motifs. This p.V133 L variant was absent in 92 non-HSCR controls. Furthermore, the rs7834206
polymorphism was associated with HSCR by case–control analysis (p = 0.037).
Conclusions: This study is the first report of a NRG1 rare variant associated with HSCR patients of South-East Asian
ancestry and provides further insights into the contribution of NRG1 in the molecular genetic pathogenesis of HSCR.
Keywords: Hirschsprung disease, Indonesia, NRG1 variant, Transcription factor binding motif

Background
Hirschsprung disease (HSCR), a heterogeneous genetic
disorder, is characterized by the lack of ganglion cells
along varying lengths of the intestines resulting in functional obstruction among children [1]. According to the
length of aganglionosis, HSCR is categorized into three
major types: short-segment (aganglionosis up to the
upper sigmoid colon), long-segment (aganglionosis up to
the splenic flexure and beyond) and total colonic aganglionosis (TCA) [1, 2].
The incidence of HSCR varies among populations with
15, 21 and 28 cases per 100,000 live births in Caucasians,
Africans and Asians, respectively [1, 2]. These differences
might be influenced by susceptibility factors such as the
REarranged during Transfection (RET) rs2435357 risk
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allele frequency [3]. Our recent studies clearly demonstrated
the presence of a higher frequency of RET rs2435357
susceptibility allele in Indonesian ancestry (50%) [4, 5].
Nevertheless, we observed that semaphorin 3 rs11766001
common variant had different effects on HSCR depending
on the ethnic background [6].
HSCR is a complex genetic disorder and at least 15 genes
have been implicated in the development of HSCR, with
the gene encoding the receptor tyrosine kinase RET
accounting for up to 21% of sporadic cases [7]. These genes
encode proteins that are important for the enteric ganglia
development and are classified into three groups: 1) those
that are associated with RET pathways (RET, GFRα1,
GDNF, NTN, PSPN); 2) those implicated in endothelin
type B receptor/EDNRB (EDNRB, EDN3, ECE-1) pathways;
and 3) transcription factors that influence both RET and/or
EDNRB pathways (SOX10, ZFXH1B, PHOX2B) [7, 8].
Neuregulin 1 (NRG1) has been implicated as a disease
susceptibility gene in Chinese [9, 10]. Both common (single
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nucleotide polymorphisms, SNPs) and rare variants of
this gene are reported to confer disease risk with
over-representation in patient cohorts. However, in the first
study on Caucasian, Luzón-Toro et al. [11] did not find any
significant association of NRG1 SNPs in Spanish HSCR
suggesting that the association of such common polymorphisms to the disease may be restricted to specific populations. Furthermore, they found three novel NRG1 rare
variants that were hypothesized to have functional consequences during embryonic development of HSCR which
could lead to HSCR in their patients. It is believed that
NRG1 plays an essential role in the signaling pathway of
the enteric nervous system (ENS) [9–12]. In addition, the
development of ENS requires a balance of neurogenesis
and gliogenesis by RET/GDNF and ERBB2/NRG1 pathways, respectively. Nrg1 suppresses Gdnf-induced neuronal
differentiation and Gdnf negatively controls Nrg1-signaling
by reducing the expression of its receptor, ErbB2 [13].
Recently, we studied two previously reported NRG1
SNPs and demonstrated that that only one common
variant rs7835688 as a genetic risk factor for Indonesian HSCR [4]. Therefore, we aimed to perform a comprehensive study of the entire NRG1 gene to investigate
fully if there is any link between NRG1 variants with
Indonesian HSCR patients.

Methods
Patients

We recruited 54 patients with HSCR, of whom 38 were
males and 16 females, corresponding to a gender ratio of
2.4:1. Diagnosis of HSCR at Dr. Sardjito Hospital,
Yogyakarta, Indonesia was based on clinical findings, contrast
enema and histopathology examinations. Hematoxillin-eosin
staining and S100 immunohistochemistry were utilized
for the histopathology assessment [4–6, 14–16]. For
controls, 92 ethnically-matched individuals with no
diagnosis of HSCR were enrolled.
The study was reviewed and approved by the Institutional
Review Board (IRB) of the Faculty of Medicine, Universitas
Gadjah Mada/Dr. Sardjito Hospital, Indonesia (KE/FK/787/
EC/2015). Written informed consent was obtained from all
parents of the subjects for this study.
Genomic DNA extraction and polymerase chain reaction
(PCR)

Genomic DNA was extracted from whole blood from
each individual by using QIAamp DNA Extraction Kit
(QIAGEN, Hilden, Germany), according to the manufacturer’s instructions. The extracted DNA samples
were stored at − 20 °C until analysis.
PCR was conducted by using a Swift Maxi thermal cycler
(Esco Micro Pte. Ltd., Singapore). The primer sequences
for NRG1 gene analysis were designed according to a previous study [10].
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DNA sequencing

To identify mutations, all 16 exons of the NRG1 that
had been PCR amplified in 20 fragments were screened
using Sanger sequencing analysis with a BigDye Terminator
V3.1 Cycle Sequencing Kit (Applied Biosystems, Foster
City, CA). The products were separated and analyzed on a
3730xl Genetic Analyzer (Applied Biosystems, Foster City,
CA) using DNA Sequencing Analysis Software (Applied
Biosystems, Foster City, CA) [17, 18].
Bioinformatics analyses

Data from the 1000 Genomes Project (http://www.interna
tionalgenome.org) and ExAC (http://exac.broadinstitute.
org) ancestry controls were utilized for comparison of variant frequencies among population. The in silico tools used
to predict coding variant effects on protein function were
SIFT (http://sift.jcvi.org/), PolyPhen-2 (http://genetics.bwh.
harvard.edu/pph2/), LRT (https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3910100/), Mutation Taster (http://www.
mutationtaster.org), Mutation Assessor (http://mutationass
essor.org/r3/), FATHMM (http://fathmm.biocompute.org.
uk), CADD (http://cadd.gs.washington.edu) algorithm
and DANN (https://cbcl.ics.uci.edu/public_data/DANN/)
(Additional file 1).
SIFT predicts whether a change of amino acid change
in a protein will have an impact on phenotype. This calculation is based on the premise that protein evolution
is correlated with protein function, the more important
positions of amino acids will correspondingly be more
conserved in an alignment of the protein family. A SIFT
score ranges from 0 to 1 and is classified as two groups:
1) predicted damaging if score ≤ 0.05; and 2) tolerated if
score > 0.05 (http://sift.jcvi.org/). PolyPhen-2 score calculates the possible effect of a change of amino acid on
the human protein structure and function. Its score
ranges from 0 to 1.0 and consists of three interpretation:
1) benign (≤ 0.452 in PolyPhen2 HDiv and ≤ 0.446 in
PolyPhen2 HVar); 2) possibly damaging (0.453 to 0.956
in PolyPhen2 HDiv and 0.447 to 0.909 in PolyPhen2
HVar); and 3) probably damaging (≥ 0.957 in PolyPhen2
HDiv and ≥ 0.909 in PolyPhen2 HVar) (http://genetics.
bwh.harvard.edu/pph2/). Mutation Taster determines
the disease potential of an alteration of amino acid using
the Bayes classifier, with four possible analysis: 1) disease
causing (i.e. probably deleterious); 2) disease causing
automatic (i.e. known to be deleterious); 3) polymorphism
(i.e. probably harmless); and 4) polymorphism automatic
(i.e. known to be harmless) (http://www.mutationtaster.org).
DANN uses deep neural network (DNN) algorithm to
predict pathogenicity of variants and scores from 0.98
to 1 are considered to be protein disrupting (Additional
file 1). All these tools predict whether a mutation leads
to damaging function that may be potentially disease
causing but it is well acknowledged that such in silico
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Table 1 Clinical characteristics of Indonesian HSCR patients
Characteristics

N (%); months

Gender
Male
Female
Age at diagnosis

38 (70)
16 (30)
34.6 ± 44.5

broadinstitute.org/genome_bio/siphy/index.html) tests. The
clinical significance of variants was analyzed using ClinVar
tool (https://www.ncbi.nlm.nih.gov/clinvar/). The HaploReg
database (https://pubs.broadinstitute.org/mammals/haploreg/
haploreg.php) was utilized to evaluate the impact of the variant by annotation of epigenomic, conservation and regulatory motif information (Additional file 1).

Degree of aganglionosis
Short segment

53 (98)

Statistical genetic analysis

Long segment

1 (2)

Chi-square test was used to establish p-values for the
case–control association analysis for NRG1 variants
(rs7834206, rs3735774, and rs75155858). A p-value less
than 0.05 was considered significant.

Age at definitive surgery

38.7 ± 43.9

Type of surgical approach
Transanal endorectal pull-through

21 (43)

Duhamel procedure

12 (25)

Soave procedure

11 (22)

Others

5 (10)

HSCR Hirschsprung disease

tools are only used as predictive guides and may not
necessarily agree with each other as they can yield conflicting results [19–21].
The predicted conservation scores of variants were determined using GERP (http://mendel.stanford.edu/SidowLab/
downloads/gerp/index.html), PhyloP (http://ccg.vital-it.ch/
mga/hg19/phylop/phylop.html), and SiPhy (http://portals.

Results
All fifty-four patients (n = 54) were sporadic non-syndromic HSCR. Neither familial nor syndromic HSCR
were included in this study. According to the degree of
aganglionosis, the distribution of the cases was 53/54
(98%) short-segment, 1/54 (2%) long-segment and none
were TCA. The mean age at diagnosis and age at definitive
operation was 34.6 ± 44.5 months (range, 1–174 months)
and 38.7 ± 43.9 months (range, 1–175 months), respectively (Table 1).
DNA analysis covering coding regions of all 16 exons
of NRG1 gene in our cohort of 54 Indonesian HSCR

Fig. 1 Sanger sequencing of NRG1 exon 7 showed a missense variant, c.397G > C, which led to substitution of valine with leucine at amino acid
133 (p.V133 L) in the NRG1 protein. The arrow indicates the mutation
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Table 2 NRG1 variants found in Indonesian HSCR patients
Variants

Reference

Nucleotide

Amino Acid

c.-97C > A

5’-UTR

c.136G > A

c.2298G > T

c.397G > C

Frequency

rs7834206

rs3735774α

p.G46R

rs75155858μ

p.G613 V

rs35641374α

p.V133 L

Cases/Allele (54/108)

Control/Allele (92/184)

Genotype

Genotype

CC: 26

CC: 59

CA: 24

CA: 31

AA: 4

AA: 2

Allele

Allele

C: 76

C: 149

A: 32

A: 35

Genotype

Genotype

GG: 47

GG: 75

GA: 6

GA: 17

AA: 1

AA: 0

Allele

Allele

G: 100

G: 167

A: 8

A: 17

Genotype

Genotype

GG: 26

GG: 39

GT: 18

GT: 42

TT: 10

TT: 11

Allele

Allele

G: 70

G: 120

T: 38

T: 64

Genotype

Genotype

GG: 53

GG: 92

GC: 1

GC: 0

CC: 0

CC: 0

Allele

Allele

G: 107

G: 184

C: 1

C: 0

Odds ratio (95% CI)

p-value

1.79 (1.03–3.11)

0.037*

0.79 (0.33–1.89)

0.59

1.02 (0.62–1.67)

0.94

, a p-value of < 0.05 was considered significant; α, NP_039253; μ, NP_039251

*

patients demonstrated the presence of four variants. These
variants were: one rare missense variant, c.397G > C,
in exon 7, which led to a substitution of valine with
leucine (p.V133 L) in one HSCR patient (Fig. 1), and
three common variants, rs7834206, rs3735774, and
rs75155858 (Table 2).

We compared the observed NRG1 rare variant allele
frequency in Indonesian HSCR patients with those reported for the 1000 Genomes Project and ExAC ancestry
controls. The frequency of c.397G > C (p.V133 L) rare
variant in our HSCR patients (0.9%) was higher than
those reported for the 1000 Genomes and ExAC

Table 3 NRG1 variants frequency in Indonesian HSCR and population databases
Variant

HSCR patients

Indonesian control

1000 Genomesμ

ExACμ

p-value
vs. 1000 Genomes

vs. ExAC

c.397G > C (p.V133 L)

0.009

0

0

0.0007

< 0.0001

< 0.0001

rs7834206

0.30

0.19

0.18

N/A

< 0.0001

N/A

rs3735774

0.07

0.09

0.09

0.07

1

1

rs75155858

0.35

0.35

0.35

0.35

1

1

*, a p-value of < 0.05 was considered significant; μ, East Asian ancestries; HSCR, Hirschsprung disease; N/A, not available

0.22 (tolerated)

0

0.36 (tolerated)

0

c.397G > C
(p.V133 L)

rs7834206

rs3735774

rs75155858

Polymorphism automatic

Polymorphism

0

Disease causing

Mutation Taster

> 0.65
< −1.5
> 15
> 0.98 (protein disrupting)
0.93–0.98 (splice site/promoter region)
< 0.93 (non-protein disrupting)

Mutation Assessor

FATHMM

CADD

DANN

> 0.999
D (disease causing) or P (polymorphism)

Mutation Taster

Polyphen2 HVAR

LRT

> 0.453
> 0.447

Polyphen2 HDIV

< 0.05

0.004 (neutral)

0

0

0 (neutral)

LRT

Deleterious cut-off

0.784 (possibly damaging)

0.004 (benign)

0

0.02 (benign)

Polyphen2 – HVAR

SIFT

0.962 (probably damaging)

0.003 (benign)

0

0.029 (benign)

Polyphen2 – HDIV

Method

Prediction scores interpretation:

SIFT

Variant

Table 4 Prediction of NRG1 variants effects on protein function

0.895 (low)

0.345 (neutral)

0

0.805 (low)

Mutation
Assessor

0.4 (tolerated)

0

0

0 (tolerated)

FATHMM

14.6 (benign)

8.83 (benign)

0

12.29 (benign)

CADD

0.9934 (protein
disrupting)

0.9957 (protein
disrupting)

0.6874 (nonprotein
disrupting)

0.9892 (protein
disrupting)

DANN

Gunadi et al. BMC Pediatrics (2018) 18:292
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ancestry controls (0 and 0.07%, respectively, p < 0.0001)
(Table 3).
Next, we analyzed the potential damaging effect of the
rare variant (p.V133 L) using the following function prediction algorithms: SIFT, PolyPhen-2 (HDiv and HVar), LRT,
Mutation Taster, Mutation Assessor, FATHMM, CADD
and DANN (Table 4). Although SIFT and PolyPhen-2 analysis of p.V133 L showed the variant as being tolerated
(0.22) and benign (0.029 in PolyPhen2 HDiv and 0.02
in PolyPhen2 HVar), respectively, p.V133 L was predicted to be disease causing by Mutation Taster and
DANN. According to the conservation scores prediction using GERP and PhyloP vertebrate, the p.V133 L
variant reached a deleterious threshold with a score of
4.26 and 1.799, respectively (Table 5) [22, 23]. However,
ClinVar reported the clinical significance of the p.V133 L
variant as likely benign (Table 6).
We then used the HaploReg database to assess the
regulatory potential of this variant. This variant was predicted to reside within a region of high mammalian conservation, overlapping with the promoter and enhancer
histone marks of relevant tissues such as digestive and
smooth muscle tissues and altering AP-4_2, BDP1_disc3,
Egr-1_known1, Egr-1_known4, HEN1_2 transcription
factor binding motifs (Table 7). When 92 Indonesian
control subjects were screened, none carried this variant,
suggesting that it is not likely to be a common variant in
our population.
Next, we compared the risk allele frequencies of the
three NRG1 common variants in 54 Indonesian HSCR
cases and 92 Indonesian controls (Table 2). For rs7834206,
the risk allele (A) has a frequency of 29.6% (32/108) in cases
as compared to 19% (35/184) in controls, and the frequency
in patients is 1.79-fold higher and significantly so (p =
0.037). The risk allele frequencies of rs3735774 (allele A)
and rs75155858 (allele T) are similar in cases and controls
[allele frequency in cases: 7.4% (8/108) and 35.2% (38/108);
in controls: 9.2% (17/184) and 34.8% (64/184), respectively,
(with p = 0.59 and 0.94), respectively] (Table 2). The

genotypes of NRG1 rs7834206, rs3735774, and rs75155858
were in Hardy–Weinberg equilibrium with the p-values of
0.37, 0.59, and 0.94, respectively.
Furthermore, we checked the rare and common variants
from previous studies [10, 11] in Indonesian HSCR patients. We could not detect any rare variant found in previous studies [10, 11] in our cohort of HSCR patients, and
the following rare variants [10] have been now considered
as common variants: p.H347Y (rs758262997), p.P356L
(rs776232660), p.A511T (rs376858256), and p.P608A
(rs201432506) (http://www.internationalgenome.org).

Discussion
In this study, we have conducted a mutational screening
of the NRG1 gene in an Indonesian cohort of HSCR patients. We found three non-synonymous variants and one
nucleotide substitution variant in the 5′ untranslated region
of the NRG1 gene. Among them, p.V133 L located in the
EGF-like domain within the NRG1 protein, was considered
a rare variant in our population since it was absent in 92
non-HSCR controls. There was conflicting results from
computational prediction programs with regards to the
pathogenicity of p.V133 L and it has been classified as
benign in ClinVar. However, the location of this variant in a
well conserved and important histone and motif binding
region suggests that it may have a regulatory function on
gene expression.
The EGF domain where p.V133 L resides has been
shown to be necessary for the activation of ErbB receptors
[24]. The variant might also affect the SOX10-mediated
maintenance of ENS progenitors since the receptors for
Nrg1 and ErbB3 are regulated by Sox10 [25, 26]. Moreover,
the ENS development involves a balance of neurogenesis
and gliogenesis by RET/GDNF and ERBB2/NRG1 pathways, respectively [13]. Therefore, we might suggest that
p.V133 L will have an effect in intestinal aganglionosis in
our HSCR patient by two mechanisms: 1) affecting the
SOX10-mediated maintenance of ENS progenitors, and 2)

Table 5 Conservation scores of NRG1 variants
Variant

GERP

PhyloP placental

PhyloP vertebrate

SiPhy

c.397G > C (p.V133 L)

4.26
(deleterious)

1.55
(non-deleterious)

1.799
(deleterious)

10.121
(non-deleterious)

rs7834206

0

0

0

0

rs3735774

5.15

2.894

0.784

9.461

rs75155858

4.71

1.321

3.472

10.265

Conservation scores interpretation:
Method

Deleterious cutoff

GERP

>2

PhyloP

> 1.6

SiPhy

> 12.17
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Table 6 Clinical significance of NRG1 variants
Variant

Clinical Significance

ClinVar ID

c.397G > C (p.V133 L)

Likely benign

RCV000202884.1

rs7834206

0

0

rs3735774

0

0

rs75155858

0

0

altering the balance of neurogenesis and gliogenesis during
ENS development.
The p.V133 L variant was absent in 92 non-HSCR
population. Thus, we considered the variant as rare in
our population. The presence of this variant was also
higher in our patients than those reported in the 1000
Genomes and ExAC ancestry controls (0.9% vs. 0 vs.
0.07%). Previous studies reported NRG1 rare variants to be
implicated in the development of ENS and HSCR [10, 11].
Interestingly, the frequency of this NRG1 rare variant found
in Indonesian [1/54 (1.8%) patients] was similar to those of
Caucasian and Chinese probands [3/207 (1.4%) and 13/358
(3.6%) patients, respectively; with p = 0.45] [10, 11]. Furthermore, the NRG1 rs7835688 common variant was originally associated with HSCR in Chinese patients [9] and
has been similarly observed in other Asian ancestry cases
[4, 27], but these associations were not replicated in any
Caucasian population [11, 28].
We were able to find evidence of the genetic effect of
NRG1 rs7834206 in Indonesian HSCR cases. Our study
shows that NRG1 rs7834206 is a genetic risk factor for
HSCR with a background allele frequency of ~ 19% in
Indonesian populations (Table 3). The risk allele at
rs7834206 (0.19 vs. 0.18) in Indonesian controls has a
similar frequency to subjects of Asian ancestry in the
1000 Genomes dataset (p = 0.80). Furthermore, a recent
meta-analysis study showed that NRG1 polymorphisms are
risk factors for HSCR in Asians but not in Caucasians [29].
Therefore, our findings strengthen the notion of the potential damaging role of NRG1 common variants in HSCR
patients of Asian ancestries. It should be noted that the
small sample size in this study poses a potential limitation
and a significantly larger number of patients are needed to
validate these observations. Future investigations on
larger cohorts will clarify the exact role of the two variants, rs7834206 and p.V133 L in HSCR in Indonesian
population. Moreover, moving beyond the prediction

effect of mutations, further in vitro or in vivo functional
studies are required to shed light on the actual effect of
any variant.
Although there have been previous studies correlating
NRG1 SNPs with disease association in HSCR, these have
only been reported in three populations, namely Chinese,
Caucasian, and Thais [10, 11, 27, 28]. Indeed, contrary to
the findings in Chinese, Luzón-Toro et al. [11] failed to
find association of NRG1 variants with HSCR phenotype
in Spanish patients and suggested that this could be due
to population differences. In the Thai patients, only four
NRG1 SNPs were selected for association studies and
disease correlation was found in Thai-Chinese but not
Thai-Muslim patients suggesting ethnicity differences
[27]. Our present study is unique in this being a comprehensive screen of NRG1 gene in Indonesian HSCR
patients. As indicated in all the above studies, it is important to verify the role of NRG1 variants in different
population groups due to ethnicity differences. Furthermore, the SNPs in this study, namely the three common
variants (rs7834206, rs3735774, and rs75155858) have not
been previously investigated in all the other reported studies [10–12]. Since the allele frequencies of some common
variants have been known to vary among different ethnic
groups within Asian population, it is thus important to
clarify the relationship of NGR1 SNPs in Indonesian patients [30].
In view of recent interest in the role of NRG1 in
HSCR, it is not surprising that there is increasing evidence showing the contributions of both common and
rare variants of this gene to disease risk. Our study
reinforces this growing body of information showing
the presence of NRG1 risk variants that may interact
with other alleles such as RET, GDNF, ErbB or SOX10
as well as other susceptibility factors in leading to
HSCR risk, and demonstrating that there are population differences in the contributions of the different
risk alleles.

Conclusion
This study is the first report of a NRG1 rare variant
associated with HSCR patients in South-East Asian
ancestry and adds insights into the role of NRG1 in the
molecular pathogenesis of HSCR.

Table 7 HaploReg v4.1 bioinformatics database search of NRG1 p.V133 L
Variant

Histone H3K4me1
(Enhancer)

Histone H3K4me3 (Promoter)

Histone H3K9ac
(Promoter)

Motifs Change

c.397G > C (p.V133 L)

Gastric

Duodenum Smooth Muscle,
Colon Smooth Muscle, Stomach
Smooth Muscle, Fetal Stomach,
Fetal Intestine Small, Fetal Intestine Large

Stomach Mucosa

AP-4_2, BDP1_disc3,
Egr-1_known1,
Egr-1_known4, HEN1_2
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